Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning (MASCAN)

September 24, 2023 updated by: Universitätsklinikum Hamburg-Eppendorf

Proof-of-principle Study for the Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning

The aim of this study is to prove feasibility and assess the diagnostic performance of a machine learning algorithm that relies on data from 3D-face scans with predefined motion-sequences and scenes (MASCAN algorithm), together with patient-specific meta-data for the prediction of difficult mask ventilation. A secondary aim of the study is to verify whether voice and breathing scans improve the performance of the algorithm. From the clinical point of view, we believe that an automated assessment would be beneficial, as it preserves time and health-care resources while acting observer-independent, thus providing a rational, reproducible risk estimation.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

423

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • University Medical Center Hamburg-Eppendorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Consecutive sampling: Adult patients that undergo ENT or OMS surgery in a tertiary care hospital who require facemask ventilation and tracheal intubation after induction of anesthesia.

Description

Inclusion Criteria:

  • Patients scheduling for ENT or OMS surgery in general anaesthesia, who require facemask ventilation and tracheal intubation after induction of anesthesia
  • Patients aged at least 18 years
  • Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
  • The patient is co-operative and available for the entire study
  • Provided informed consent/patient representative

Exclusion Criteria:

  • Pregnant or breastfeeding woman
  • Rapid sequence induction or other contraindications for facemask ventilation
  • Planned awake tracheal intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Study cohort
Patients undergoing ENT or OMS surgery with general anesthesia with facemask ventilation and tracheal intubation (observational)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficult facemask ventilation
Time Frame: 1 hour
Observed difficult facemask ventilation after induction of anesthesia
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficult tracheal intubation
Time Frame: 1 hour
Observed difficult intubation after induction of anesthesia
1 hour
Difficult laryngoscopy
Time Frame: 1 hour
Observed difficult laryngoscopy after induction of anesthesia
1 hour
Number of attempts
Time Frame: 1 hour
Observed during tracheal intubation
1 hour
Failed direct laryngoscopy
Time Frame: 1 hour
Observed during airwaymanagement
1 hour
Cormack Lehane grade
Time Frame: 1 hour
Grading of the best view obtained during laryngoscopy (I-IV)
1 hour
Difficult mask ventilation alert
Time Frame: 1 hour
Noted by the responsible anaesthesiologist after airway management
1 hour
Difficult intubation alert
Time Frame: 1 hour
Noted by the responsible anaesthesiologist after airway management
1 hour
Intubation time
Time Frame: 1 hour
Recorded during airwaymanagement
1 hour
Time to sufficient mask ventilation
Time Frame: 1 hour
Recorded during airwaymanagement
1 hour
Classification of intubation difficulty
Time Frame: 1 hour
VIDIAC score rating between -1 and 5 points
1 hour
Percentage of glottis opening (POGO)
Time Frame: 1 hour
Grading of the best view obtained during laryngoscopy (%)
1 hour
Impossible facemask ventilation
Time Frame: 1 hour
Observed impossible facemask ventilation after induction of anesthesia
1 hour
Successful first attempt intubation
Time Frame: 1 hour
Observed during airway management
1 hour
Airway-related adverse events
Time Frame: 1 hour
Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia
1 hour
Post-intubation recommendation for an intubation method
Time Frame: 1 hour
Recommendation of the responsible anaesthesiologist after airwaymanagement
1 hour
Minimal peripheral oxygen saturation (SpO2)
Time Frame: 1 hour
Observed after induction of anesthesia
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Petzoldt, MD, Universitätsklinikum Hamburg-Eppendorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2022

Primary Completion (Actual)

May 15, 2023

Study Completion (Actual)

May 15, 2023

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Actual)

September 26, 2023

Last Update Submitted That Met QC Criteria

September 24, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-100811-BO-ff

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anesthesia

Subscribe